Showing results (111-120 of 236) with videos related to
Sort By:
Pageof 24
The Journal of Antimicrobial Chemotherapy|July 5, 2021
Efficacy assessment of lysin CF-296 in addition to daptomycin or vancomycin against Staphylococcus aureus in the murine thigh infection modelTomefa E Asempa, Nicole A DeRosa, Cara Cassino, et al.Infection and Immunity|June 18, 2002
Cysteine protease activity and histamine release from the human mast cell line HMC-1 stimulated by recombinant streptococcal pyrogenic exotoxin B/streptococcal cysteine proteaseYukino Watanabe, Yuko Todome, Hisashi Ohkuni, et al.Proceedings of the National Academy of Sciences of the United States of America|April 22, 2017
Lysibodies are IgG Fc fusions with lysin binding domains targeting <i>Staphylococcus aureus</i> wall carbohydrates for effective phagocytosisAssaf Raz, Anna Serrano, Christine Lawson, et al.Microbiology Spectrum|August 10, 2023
Rapid bacteriolysis of <i>Staphylococcus aureus</i> by lysin exebacaseXavier Vila-Farres, Karen Sauve, Jun Oh, et al.Bacteriophage|January 1, 2013
Development of a high throughput assay for indirectly measuring phage growth using the OmniLog(TM) systemMatthew Henry, Biswajit Biswas, Leah Vincent, et al.EMBO Molecular Medicine|June 17, 2021
The global emergence of a novel Streptococcus suis clade associated with human infectionsXingxing Dong, Yanjie Chao, Yang Zhou, et al.Plos One|October 21, 2015
Streptococcus pyogenes Sortase Mutants Are Highly Susceptible to Killing by Host Factors Due to Aberrant Envelope PhysiologyAssaf Raz, Ana-Maria Tanasescu, Anna M Zhao, et al.Msphere|June 5, 2023
Therapeutic potential of Md Huzzatul Mursalin, Roger Astley, Phillip S Coburn, et al.Infection and Immunity|March 24, 2005
Clinical and microbiological responses of volunteers to combined intranasal and oral inoculation with a Streptococcus gordonii carrier strain intended for future use as a group A streptococcus vaccineKaren L Kotloff, Steven S Wasserman, Kevin F Jones, et al.Antimicrobial Agents and Chemotherapy|January 24, 2019
The Antistaphylococcal Lysin, CF-301, Activates Key Host Factors in Human Blood To Potentiate Methicillin-Resistant <i>Staphylococcus aureus</i> BacteriolysisChiara Indiani, Karen Sauve, Assaf Raz, et al.Pageof 24